SunGen Pharma 製藥獲得美國 FDA 的第八個 ANDA 批准
31 oct. 2019 13h51 HE
|
SunGen Pharma LLC
新澤西州普林斯頓市, Nov. 01, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, 一家私人控股的研發，生產，和銷售製劑產品的製藥公司,今天宣布其已獲得美國食品與藥物管理局（FDA）的第八個ANDA文號批准。 第八個ANDA的產品名為利多卡因軟膏 5% (Lidocaine Ointment USP 5%), 每管規格為1.5盎司（35.44克）...
SunGen Pharma 制药获得美国 FDA 的第八个 ANDA 批准
31 oct. 2019 13h51 HE
|
SunGen Pharma LLC
新泽西州普林斯顿市, Nov. 01, 2019 (GLOBE NEWSWIRE) -- 2019 年 10 月 31 日: SunGen Pharma, 一家私人控股的研发，生产，和销售制剂产品的制药公司,今天宣布其已获得美国食品与药物管理局（FDA）的第八个 ANDA文号批准。 第八个ANDA的产品名为利多卡因软膏 5% (Lidocaine Ointment USP 5%),...
SunGen Pharma Receives Eighth ANDA Approval from US FDA
31 oct. 2019 13h51 HE
|
SunGen Pharma LLC
PRINCETON, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
SunGen Pharma 製藥獲得美國 FDA 的第七個 ANDA 批准
05 sept. 2019 21h25 HE
|
SunGen Pharma LLC
新澤西州普林斯頓市, Sept. 06, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, 一家私人控股的研發，生產，和銷售製劑產品的製藥公司，今天宣佈其已獲得美國食品與藥物管理局（FDA）的第七個ANDA文號批准 。 第七個ANDA的產品名為註射液福沙匹坦（Fosapreptant for Injection），規格為150mg...
SunGen Pharma 制药获得美国 FDA 的第七个 ANDA 批准
05 sept. 2019 21h25 HE
|
SunGen Pharma LLC
新泽西州普林斯顿市, Sept. 06, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, 一家私人控股的研发，生产，和销售制剂产品的制药公司,今天宣布其已获得美国食品与药物管理局（FDA）的第七个 ANDA文号 批准。 第七个ANDA的产品名为注射液福沙匹坦 (Fosapreptant for Injection),...
SunGen Pharma Receives Seventh ANDA Approval from US FDA
05 sept. 2019 21h25 HE
|
SunGen Pharma LLC
PRINCETON, N.J., Sept. 05, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished...
SunGen Pharma Announces to Partner with Athenex Pharmaceutical to Launch Bivalirudin through PIV Challenges in US
27 juin 2019 08h00 HE
|
SunGen Pharma LLC
PRINCETON, N.J., June 27, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
SunGen Pharma Receives its Fourth and Fifth ANDA Approvals from US FDA
29 avr. 2019 14h50 HE
|
SunGen Pharma LLC
PRINCETON, N.J., April 29, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished...
SunGen Pharma and Athenex Pharmaceutical Division Announce Busulfan Injection Product Launch
13 mars 2019 07h00 HE
|
SunGen Pharma LLC
PRINCETON, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished...
Elite Pharmaceuticals and SunGen Pharma File ANDA for an Antibiotic
03 janv. 2019 07h30 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...